Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
C1orf106 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
TUSC3 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
RAB3B - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
GEO DataSets Profile neighbors
SNCB - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
SGPL1 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
SERPINA1 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
LIG1 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
CMTR1 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
EXT2 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
SLC1A1 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
TMEM51 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
FIBP - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
CD40 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
DNPH1 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
KLK2 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
NDUFB1 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
EPS8L2 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
OSBPL2 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
TNIP1 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on